www.rapidai.com/Healthcare / Healthcare softwareFounded: 2011Funding to Date: $93.84MM
RapidAI is a diagnostic technology company that uses neuroimaging analysis to make accurate diagnostic decisions for aneurysm and stroke patients. With clinical trial solutions, RapidAI has a mission of redefining traditional neurologic care and uses software to advance medical technology. The company also features analytic insights to improve operational care. RapidAI was founded by Gregory Albers and Karim Karti in 2011 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/27/2023 | Series C | $75MM | $xx.xx | $667.51MM | Vista Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,352,828
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Vista Equity Partners
|
||||||
09/17/2020 | Series B | $15.68MM | $xx.xx | $292.23MM | Lennertz & Company | |
Price per Share
$xx.xx
Shares Outstanding
550,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Lennertz & Company
|
||||||
01/01/2014 | Series A | $3.16MM | $xx.xx | $15.79MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,500,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|